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In this study, we present the commissioning and validation results of a dedicated scanning nozzle. The dedicated 
scanning nozzle is installed in one of the two gantry treatment rooms at Samsung Proton Therapy Center. 
Following a successful completion of the acceptance test, the commissioning process including the beam data 
measurement for treatment planning system has been conducted. Extended measurements have been conducted 
as a validation of the clinical performance of the nozzle and various quality assurance protocols have been 
prepared.
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Introduction
  The possibility of therapeutic use of fast protons is in-
troduced in 1946.1) Ever since the introduction of radiological 
use of fast protons, there have been uninterrupted development 
of proton beam therapy and recently, number of proton therapy 
centers in operation or in preparation is rapidly increasing.2) 
One of the most noticeable contemporary trend in proton ther-
apy is the wide adaptation of pencil beam scanning technique 
in newly installed proton therapy systems. While there are still 
significant advantages in passive scattering mode of proton 
beam delivery over conventional x-ray radiation therapy, the 
pencil beam scanning technique can maximize the benefits of 
proton therapy considering the intensity modulation and dose 
conformality (especially in proximal region). 
  The Samsung Proton Therapy Center (Samsung PTC) is the 
first private hospital based proton therapy center in Korea,3) 
and it has provided stable scanning beam treatments for many 
patients since its first operation of the dedicated scanning 
nozzle. Even though there are several reports on commission-
ing of pencil beam scanning nozzles recently published, the 
proton therapy system (Sumitomo Proton Therapy System, 
Sumitomo Heavy Industries, Ltd.) installed at Samsung PTC 
has its own unique characteristics for both wobbling nozzle 
and line scanning nozzle compared to other proton therapy 
systems provided by other vendors. In addition, there is no 
published study about Sumitomo’s system as far as we know. 
It is our main purpose to report the details of commissioning 
and validation of the dedicated scanning nozzle at Samsung 
PTC, and thus provide a practical guide for upcoming proton 
therapy centers.
Materials and Methods
  The dedicated scanning nozzle at Samsung PTC has a max-
imum field size of 30 cm×40 cm and its detailed specification 
can be found elsewhere.4) In principle, the line-scanning nozzle 
can be also operated in spot-scanning mode as both beam de-
livery methods share the same hardware. Nevertheless, in prac-
tice, the selected line-scanning mode was exclusively im-
plemented, as the spot-scanning mode would require a separate 
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control sequence. The nozzle was installed by the vendor 
(Sumitomo Heavy Industries, Ltd.). The dedicated scanning 
nozzle differs from the multi-purpose nozzle, which is installed 
in the other treatment room at Samsung PTC in several aspects. 
All the nozzle components related to the wobbling method 
have been removed and a helium gas filled chamber has been 
located at the down stream of the nozzle to improve beam 
quality mainly by reducing in air scattering of the proton beam. 
  The modeling of a line scanning nozzle has required an ad-
ditional process in the treatment planning system’s viewpoint. 
In RayStation (RaySearch Laboratories, AB, Stockholm, 
Sweden), the existing dose calculation algorithm for spot scan-
ning proton beam has to be converted to a new algorithm for 
the line scanning proton beam. The simplest approach was to 
use a concept of “line segment” which is equivalent to an in-
dividual spot in spot scanning method. While there were mod-
ifications in the dose calculation algorithms with the vendor 
provided machine limits (minimum scan speed, maximum scan 
speed, and maximum dose rate), the fundamental requirement 
for beam data measurement remains the same as the spot scan-
ning beam modeling: integrated depth dose curves, absolute 
dose measurements, and in-air spot profiles (for selected beam 
energies). As recommended in the beam data requirements, we 
have selected 30 different beam energies including the max-
imum and minimum beam energies can be delivered in the 
nozzle. These selected beam energies have been used for all 
beam data measurements. The integrated depth dose curve for 
each energy has been measured using a Bragg peak chamber 
(PTW, Freiburg, Germany). The water-equivalent thickness 
(WET) of the chamber window has been applied either as an 
offset in the measurement setup or as a shift in the acquired 
integrated depth dose (IDD) curves. The absolute dose meas-
urement was performed with a parallel plate chamber for those 
selected beam energies. The measurement depths have been 
chosen from points in the plateau region (around the mid-point 
from the entrance surface to the half distance of the maximum 
range) of the integrated depth dose curves. This is a practical 
and reasonable choice as the dose gradient near the Bragg 
peak is fast-changing compared to that of the plateau region. 
After taking the entire beam data required, the data have been 
sent to RaySearch for beam modeling. Along with the meas-
ured beam data, the related hardware specifications (maximum 
field size, maximum and minimum dose rate, etc.) have also 
been sent. As this was the first use case of RayStation for 
Sumitomo Proton Therapy System (PTS), another dataset has 
to be sent for validation purpose. For this validation dataset, 
we have selected different beam energies for additional IDD 
curves, and various geometrical plans have been created for 
measurements. After a successful validation of the beam model, 
the first ever-modeled Sumitomo line scanning nozzle in 
RayStation has been delivered to Samsung PTC. 
  Using the delivered machine model, we have started the 
commissioning of the dedicated scanning nozzle at Samsung 
PTC. The commissioning procedure evolved in three steps in-
cluding physical, clinical, and total commissioning. In the 
physical commissioning, the main focus was in the physical 
properties of the line scanning nozzle. It started with the most 
fundamental item, the standard quality assurance (QA). The 
standard QA is a daily output calibration and thus needs to be 
conducted every morning prior to daily patient treatments. The 
standard QA plan has been designed to deliver a uniform two 
Gy dose in a 10 cm3 cube with a maximum energy layer of 
230 MeV in water. Based on the result of the standard QA, a 
correction factor (beta-value) for count/Gy would be de-
termined and recorded in the treatment control system client 
(TCSC) database. In addition to the daily output calibration, 
scan patterns for two different beam energies have been pre-
pared for a daily QA. The SOBP range has also been meas-
ured as a daily QA item by using a multi-layer ionization 
chamber (MLIC). After the settlement of daily QA procedure, 
the daily QA has been conducted routinely. As the perform-
ance of the line scanning nozzle is highly sensitive to the cy-
clotron beam current, if necessary, the cyclotron beam current 
table has to be re-generated every four hours. 
  The clinical commissioning was prepared with an anthro-
pomorphic phantom (ATOM, Computerized Imaging Reference 
Systems, Inc., Virginia, US). For various disease sites, the 
phantom has been CT-scanned with appropriate immobilization 
devices and setup position. Following the prepared proton plan 
protocol for a given disease site, treatment plans for nine dif-
ferent patient cases were created in RayStation (version 5.0) 
and exported to the MOSAIQ system. All the patient cases 
went through the patient-calibration procedure which is a re-
quirement for treatment beam delivery in the Sumitomo PTS. 
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Fig. 1. The integrated depth dose curves for the selected beam 
energies (normalized at peak values).
Fig. 2. The clinical range (D90) of the dedicated scanning nozzle 
at Samsung PTC measured by PTW Bragg peak chamber and 
MLIC.
The patient specific QA for scanning plan includes both the 
patient-calibration and a gamma evaluation of two dimensional 
dose distribution in 2 or 3 different depths depending on the 
maximum range of treatment fields. For a selected case, we 
have measured two dimensional dose distribution in every 1 
cm depth considering the resolution of the 2D detector 
(OCTAVIUS 729XDR, PTW Freiburg, Germany), and then re-
constructed a three dimensional dose map of the treatment 
field out of the multi-depth measurements. This method has al-
so been used to evaluate the gamma passing rate in longi-
tudinal planes (XZ and YZ planes, where Z is the beam direc-
tion) which was one of the remained item of the acceptance 
test due to the technical challenges. 
  The total commissioning of the dedicated scanning nozzle 
was an integrated end-to-end test of line scanning treatment. 
Using the clinical commissioning phantom cases, the whole 
procedures including simulation, treatment planning, patient 
specific QA, treatment data transfer through MOSAIQ system, 
image verification using orthogonal X-ray images or CBCT 
images, and actual beam delivery in treatment mode.
Results
  The IDD curves of a spot proton beam have been measured 
for 30 different proton beam energies as shown in Fig. 1. 
From the measured IDD curves, clinical ranges D90 (distal 
90% of the integrated depth dose curve for a given proton 
beam energy) have been determined. As a validation, scanned 
mono-energy plans (10 cm×10 cm) have been created in the 
treatment planning system for the selected beam energies and 
then delivered for MLIC measurements. The ranges have been 
compared as shown in Fig. 2. The ranges measured for beam 
modeling and for validation have agreed well within the reso-
lution of MLIC (2 mm with a single measurement).
  For those selected beam energies, in-air spot profiles have 
been measured on the planes with different distances from the 
isocenter (−20, −10, 0, 10, 20 cm). We have used a 
pin-point chamber in a 2D scan mode of OmniPro Accept 
(IBA Dosimetry GmBH, Germany). The spot profiles in x-axis 
and y-axis have been extracted from the scanned 2D 
distributions. In order to determine the spot size at the center 
of isocenter plane for different beam energies, we have first 
read the FWHM (Full Width Half Maximum) values from the 
spot profiles and then converted to 1-sigma values using the 
relation between FWHM and 1-sigma of a single Gaussian 
function. For the maximum (minimum) beam energy, the spot 
size is 2.9 mm (9.0 mm). The spot sizes for several beam en-
ergies are shown in Fig. 3. 
  For daily output calibrations, 10×10×10 cm3 cube plan (2 
cGy uniform dose) has been used. This cube plan is the same 
plan used for the absolute MU calibration of the nozzle. At 
the time of the absolute MU calibration, the beam model in 
RayStation was not available and thus the cube plan has to be 
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Fig. 4. Example of mono ener-
getic scan patterns (Left: 150 MeV, 
Right: 190 MeV) created for vali-
dation and daily QA. The gamma 
passing rates were all above 95% 
with 3%, 3 mm criteria for both 
beam energies.
Fig. 3. The spot size calculated in one sigma for selected beam 
energies. 
generated by a manual weighting of 10×10 cm2 single layered 
(mono energy) components with relevant beam energies. The 
initial weights were analytically calculated from the measure-
ments of each layer. After several iterations of adjustment of 
weights and measurements, the final weights have been de-
cided with a satisfactory flatness and uniformity. In the line 
scanning nozzle, the absolute output can be controlled by dose 
rate and scan speed. The lower dose rate yields lower output 
while the lower scan speed yields higher output. Both dose 
rate and scan speed have their own physical limit specified by 
the relevant machine components. Within the machine limits, 
in principle, the same output can be achieved by a certain 
combination of the dose rate and scan speed. At the final 
stage of the standard QA plan set up, the dose rate of the 
composite layers in the cube plan has been fine-tuned to get 
an exact 2 cGy output reading. The same cube plan has also 
been used for daily range verification. In addition to the stand-
ard output calibration plan, a 2D dose verification of a geo-
metric scan pattern (Fig. 4) has been added into the daily QA. 
The two dimensional dose distributions on the same effective 
depth as the detector plane (0.9 mm water-equivalent-thickness 
without a build-up material) have been measured and com-
pared with the dose plane exported from the treatment plan-
ning system. The gamma passing rates were all above 95% 
with 3%, 3 mm criteria, although the passing rates were de-
pendent on beam energies. Later on, the scan pattern has been 
replaced by a simplified geometry to avoid casual interruptions 
due to machine limit approaching beam conditions. 
  The output calibration for a treatment plan is a mandatory 
procedure in Sumitomo PTS. Based on the output calibration 
result, a correction factor (gamma-factor) is determined and re-
corded in the treatment control system database. Patient specif-
ic QA plans are generated by painting the treatment field dose 
on a solid water phantom registered in the treatment planning 
system. The output measurement points are decided in rela-
tively uniform dose region where the point dose is similar to 
the originally specified dose on the point of interest. Two di-
mensional dose distributions were additional measured for the 
patient specific QA. The measurement depths always include 
the same depth of the output measurement, one shallow depth 
(2 cm), and optionally one more depth in between in case the 
maximum range of the treatment field is relatively long. At 
the commissioning stage, we have practiced patient specific 
QA for nine selected patient cases as listed in Table 1. All the 
output calibration results were well within 3% and the gamma 
PROGRESS in MEDICAL PHYSICS  Vol. 27, No. 4, December, 2016
- 271 -
Table 1. Selected rehearsal cases for the physical and 
clinical commissioning of the dedicated scanning nozzle.
Case 
number
Dx. Site *2D Dose QA Note
1 PED 99.0% CSI
2 HCC 97.8%
3 Brain 98.1%
4 Lung 98.5%
5 PED 99.5% Brain
6 Recurrent rectal 98.8%
7 Head and neck 99.3%
8 Prostate 99.5% Definitive
9 Esophagus 97.5% Long Y-extent
*2D Dose QA: the gamma passing rate of the treatment field 
with the lowest value.
Fig. 5. Pseudo 3D dose distribution reconstructed from multi- 
depth measurement of 2D dose map (With 3% and 3 mm criteria, 
all XY, XZ, and YZ planes have a passing rate of 100%).
passing rate of the 2D dose measurements were above 97.5% 
as listed in Table 1. A special 2D dose distribution verification 
has been performed for the case number 4. The OCTAVIUS 
729XDR has two dimensional array of ionization chambers 
with a spacing of 1 cm in both horizontal and vertical 
direction. A finer resolution can be obtained by merging a set 
of measurement with shifted detector planes. The analysis soft-
ware for OCTAVIUS 729XDR provides a function of manual 
dose map editing. Using this feature, we have reconstructed a 
pseudo 3 dimensional dose distribution from a multi-depth 
measurement in every 1 cm depth as shown in Fig. 5. With 
3% and 3 mm gamma evaluation criteria, all XY, XZ, and YZ 
planes have a passing rate of 100%. When tighter criteria were 
applied (2% and 2 mm), the passing rates were above 89%. 
Not only a measurement of three dimensional dose dis-
tributions, but also a measurement of dose distribution in lon-
gitudinal direction is very challenging as there is no perfect 
solution available at least to our knowledge. Even though the 
multi-measurement method is practically inefficient for daily 
QA, it can be used as an excellent validation method, and we 
have indeed adopted this method successfully to finalize the 
remained AT items. 
Conclusion
  We have presented commissioning and validation results of 
the dedicated scanning nozzle at Samsung PTC. Despite of a 
tight schedule and limited resources, we have successfully fin-
ished the end-to-end test of the nozzle including the beam 
modeling for treatment planning system, the validation of the 
beam model, physical and clinical commission, and the in-
tegration of all composite parts. We have also verified that the 
accuracy and precision of the treatment nozzle stay within the 
clinical specifications, and developed the QA protocols to 
guarantee the stability of the nozzle performance. 
  Compared to the well-known and relatively simple photon 
radiotherapy devices, the clinical set up of a proton therapy 
system in general requires a prodigious resources and ex-
periences. By representing the commissioning and validation 
experiences at Samsung PTC in this study, we would expect 
that it could be used as a pivotal guide to imminent proton 
therapy centers.
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